Supernus Pharmaceuticals Basic EPS 2011-2024 | SUPN

Supernus Pharmaceuticals basic eps from 2011 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
Supernus Pharmaceuticals Annual Basic EPS
2023 $0.02
2022 $1.13
2021 $1.01
2020 $2.41
2019 $2.16
2018 $2.13
2017 $1.13
2016 $1.84
2015 $0.29
2014 $-0.26
2013 $-2.90
2012 $-2.72
2011 $31.39
2010 $-26.38
Supernus Pharmaceuticals Quarterly Basic EPS
2024-09-30 $0.70
2024-06-30 $0.36
2024-03-31 $0.00
2023-12-31 $0.02
2023-09-30 $-0.29
2023-06-30 $-0.02
2023-03-31 $0.31
2022-12-31 $0.47
2022-09-30 $0.03
2022-06-30 $0.15
2022-03-31 $0.48
2021-12-31 $0.04
2021-09-30 $0.41
2021-06-30 $0.45
2021-03-31 $0.11
2020-12-31 $0.58
2020-09-30 $0.76
2020-06-30 $0.66
2020-03-31 $0.41
2019-12-31 $0.64
2019-09-30 $0.55
2019-06-30 $0.62
2019-03-31 $0.35
2018-12-31 $0.49
2018-09-30 $0.54
2018-06-30 $0.59
2018-03-31 $0.51
2017-12-31 $0.27
2017-09-30 $0.31
2017-06-30 $0.34
2017-03-31 $0.21
2016-12-31 $0.28
2016-09-30 $1.25
2016-06-30 $0.21
2016-03-31 $0.10
2015-12-31 $0.14
2015-09-30 $0.08
2015-06-30 $0.05
2015-03-31 $0.02
2014-12-31 $0.10
2014-09-30 $-0.06
2014-06-30 $0.08
2014-03-31 $-0.38
2013-12-31 $-0.63
2013-09-30 $-0.78
2013-06-30 $-0.89
2013-03-31 $-0.60
2012-12-31 $4.49
2012-09-30 $-0.55
2012-06-30 $-0.61
2012-03-31 $-6.05
2011-12-31 $40.14
2011-09-30 $-6.64
2011-06-30 $-5.17
2011-03-31 $-7.48
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.089B $0.608B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.384B 6.36
Dr Reddy's Laboratories (RDY) India $12.329B 23.59
BridgeBio Pharma (BBIO) United States $4.629B 0.00
Bausch Health Cos (BHC) Canada $3.358B 2.43
Amphastar Pharmaceuticals (AMPH) United States $2.294B 13.79
Taysha Gene Therapies (TSHA) United States $0.490B 79.67
Personalis (PSNL) United States $0.278B 0.00
Assembly Biosciences (ASMB) United States $0.105B 0.00
Sol-Gel Technologies (SLGL) Israel $0.016B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00